General Information of Drug (ID: DMQ8DWR)

Drug Name
Pivagabine
Synonyms
4-Pivalamidobutanoic acid; 69542-93-4; 4-[(2,2-dimethylpropanoyl)amino]butanoic acid; UNII-C53SV0WO4V; Pivagabine [INN]; C53SV0WO4V; Pivagabine (INN); NCGC00160457-01; 4-(2,2-dimethylpropanamido)butanoic acid; 4-[(2,2-dimethylpropionyl)amino]butyric acid; DSSTox_CID_26162; DSSTox_RID_81393; DSSTox_GSID_46162; 4-(2,2-DIMETHYLPROPIONYLAMINO)BUTYRIC ACID; Tonerg; CAS-69542-93-4; 4-((2,2-Dimethylpropionyl)amino)butyric acid; SR-01000945179; CXB-722; EINECS 274-038-3; N-Trimethylacetyl-4-aminobutyric acid; CXB-722; CXB722
Indication
Disease Entry ICD 11 Status REF
Anxiety disorder 6B00-6B0Z Phase 1 [1]
Depression 6A70-6A7Z Phase 1 [1]
ATC Code
N06AX15: Pivagabine
N06AX: Other antidepressants
N06A: ANTIDEPRESSANTS
N06: PSYCHOANALEPTICS
N: NERVOUS SYSTEM
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C9H17NO3
Canonical SMILES
CC(C)(C)C(=O)NCCCC(=O)O
InChI
InChI=1S/C9H17NO3/c1-9(2,3)8(13)10-6-4-5-7(11)12/h4-6H2,1-3H3,(H,10,13)(H,11,12)
InChIKey
SRPNQDXRVRCTNK-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
68888
ChEBI ID
CHEMBL134834
CAS Number
69542-93-4
UNII
C53SV0WO4V
DrugBank ID
DB12951
TTD ID
D0R8PE
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 ClinicalTrials.gov (NCT00814931) Examining the Effects of CXB722 in Neuroendocrine Stress Response in Healthy Males. U.S. National Institutes of Health.